On September 12th this week, Hexoskin's Co-founder & CTO Jean-François Roy will discuss sensors, data, and AI in medicine at the Intelligent Health AI conference in Basel, Switzerland.
Hexoskin has been chosen among only 5 companies in the world to present at the Showcase event at the conference sponsored by Novartis. Hexoskin's Chief Technology Officer Jean-François Roy will present new opportunities for healthcare and pharmaceutical organizations to uncover new insights from the data they have collected from clinical trials.
Artificial Intelligence and Machine Learning have the potential to transform drug development and reduce the time to market of much-needed therapies in various therapeutic areas, including rare diseases, and find new cures for millions of patients.
The Hexoskin end-to-end data platform is secure and platform agnostic. Hexoskin's clients have access to cost-effective tools to manage clinical studies, collect rich health data, and build unique databases and datasets for machine learning & AI projects.
Hexoskin has a dedicated group of AI & biomedical researchers with years of experience in preparing and analyzing health data, and in the development of machine learning algorithms with health data. Its research team collects new vital signs data and use external datasets to answer novel research questions.
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.
The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 70 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients including pharmaceuticals, research centers, government agencies, and healthcare providers.